Abstract:We conducted a cross-sectional study of Chagas disease in five endemic areas in Argentina, Bolivia, Honduras, and México to estimate the prevalence of Trypanosoma cruzi-specific antibodies in pregnant women, and to assess the use of a rapid test (Chagas Stat-Pak) to screen for T. cruzi infection at the time of delivery. The prevalence of antibodies to T. cruzi measured by enzyme-linked immunosorbent assay (ELISA) in maternal blood was 5.5% (a range of 0.8-28.8% among the countries) in 2,495 women enrolled. Com… Show more
“…Immunochromatographic dipstick tests have been developed for a range of tropical diseases, including malaria (31), leishmaniasis (7), and schistosomiasis (3); until recently (4,5,8,14,17,20,25,28,30), none was available for Chagas disease.…”
We evaluated a commercially available immunochromatographic dipstick test to detect Trypanosoma cruzi infection in 366 human serum samples with known serological results from Argentina, Ecuador, Mexico, and Venezuela. One hundred forty-nine of 366 (40.7%) and 171/366 (46.7%) samples tested positive by dipstick and serology, respectively. Dipstick sensitivity was calculated to be 84.8% (range between countries, 77.5 to 95%), and specificity was 97.9% (95.9 to 100%).
“…Immunochromatographic dipstick tests have been developed for a range of tropical diseases, including malaria (31), leishmaniasis (7), and schistosomiasis (3); until recently (4,5,8,14,17,20,25,28,30), none was available for Chagas disease.…”
We evaluated a commercially available immunochromatographic dipstick test to detect Trypanosoma cruzi infection in 366 human serum samples with known serological results from Argentina, Ecuador, Mexico, and Venezuela. One hundred forty-nine of 366 (40.7%) and 171/366 (46.7%) samples tested positive by dipstick and serology, respectively. Dipstick sensitivity was calculated to be 84.8% (range between countries, 77.5 to 95%), and specificity was 97.9% (95.9 to 100%).
“…25 We studied 2,495 pregnant women in Argentina, Bolivia, Honduras, and Mexico and found a sensitivity of 94.6% and a specificity of 99.0% for the Chagas Stat-Pak in cord blood compared with the Wiener ELISA in maternal blood. 18 We also compared these commercial tests (Stat-Pak and ELISA Wiener) with non-commercial tests using a local Mexican strain of T. cruzi and found similar results for both tests in umbilical cord blood samples. 19 Blood samples were centrifuged, and serum samples (5 μL) were used for Stat-Pak rapid tests according to the manufacturer's instructions.…”
Section: Methodsmentioning
confidence: 99%
“…16 We estimated in a previous article that about 37,000 pregnant women and 1,800 newborns are likely to be infected with T. cruzi in Mexico. 17 In a recent study, we identified 5 seropositive mothers of 500 women who gave birth at an urban hospital in Mérida, Yucatá n. 18 Newborn children of seropositive mothers were tested for presence of T. cruzi antibodies 10 months after birth to determine potential congenital infection. None of the children were seropositive.…”
Abstract. Our objective was to determine the seroprevalence of Trypanosoma cruzi infection among mothers and children in two rural Mayan communities in Yucatan, Mexico and examine sociodemographic characteristics and adverse reproductive outcomes associated with maternal infection. We performed household surveys in the communities of Sudzal and Teya. Mothers were interviewed, and blood samples were obtained to perform rapid tests and enzyme-linked immunosorbent assays (ELISAs). We surveyed 390 mothers and 685 children. The overall seroprevalence was 2.3% among mothers and 0.4% among children. In Sudzal, we found a seroprevalence of 4.4% among mothers and 0.7% in children. In Teya, we found a seroprevalence of 0.9% among mothers and 0.3% among children. Compared with uninfected mothers, seropositive mothers reported more stillbirths (relative risk = 4.7; 95% confidence interval = 2.1-10.4). T. cruzi infection is present in these communities, and infected children indicate active transmission. Seropositivity in mothers is associated with a history of adverse reproductive outcomes.
“…96%. (Ponce et al, 2005;Brutus et al, 2008;Roddy et al, 2008;Sosa-Estani et al, 2008) The fundamental problems of T. cruzi infection serological diagnostic methods are the lack of reproducibility that sometimes occur, deficient immunological reaction specificity, what produces false-positive results, and the occasional insufficient sensitivity translated into false-negative outcomes. Chagasic infection serology tests may produce cross-reactions with antibodies produced during the course of other illnesses.…”
Section: Serological Diagnosis Of Chronic Entitiesmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.